Worth reading
54Recurring
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
5873
Millions of yen (year-on-year change in net sales)Wording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPNet Sales138,155Millions of yenYear on year +4.4%Progress 103.1%
Operating profit14,814Millions of yenYear on year -1.2%Progress 98.8%
Ordinary income19,667Millions of yenYear on year -1.3%Progress 103.5%
Net income attributable to owners of the parent12,940Millions of yenYear on year -1.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥117.16
Operating Margin10.7%
Financial position at period-end
Total assets273,094Millions of yen
of which net assets 221,457 Millions of yenEquity ratio 73.9%vs. prior year-end +0.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+25,402
Investment+617
Financials-25,857
Net change+162
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period53,849 Millions of yen
Segment revenuePharmaceuticals business 58,919 Millions of yen (YoY +2.3%), Equipment business 27,621 Millions of yen (YoY +14.1%), Processing Business 48,570 Millions of yen (YoY +1.7%), Other (outside reportable segments) 3,043 Millions of yen (YoY +12.6%)
Segment profitPharmaceuticals business 9,363 Millions of yen (YoY -9.4%), Equipment business 2,116 Millions of yen (YoY +208.5%), Processing Business 4,675 Millions of yen (YoY -6.8%), Other (outside reportable segments) -19 Millions of yen (YoY -125.4%)
Regional sales82,940 Millions of yen (YoY +3.6%), 48,892 Millions of yen (YoY +7.2%), 11,689 Millions of yen (YoY -3.8%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales134,000 Millions of yen (YoY -3.0%)
Operating profit15,000 Millions of yen (YoY +1.3%)
Ordinary income19,000 Millions of yen (YoY -3.4%)
Profit attributable to owners of the parent14,000 Millions of yen (YoY +8.2%)
Annual Dividend Forecast¥50 per share → ¥50 per share（0.0%）
Payout ratioActual results for the fiscal year ending March 2026 42.7 % / Forecast for the fiscal year ending March 2027 35.8 %
Shareholder Return PolicyA consolidated dividend payout ratio of 30% is the target. The Company intends to maintain stable dividends and take the total payout ratio into consideration while flexibly conducting share repurchases.
Factors Behind Changes in Business Performance
Net sales increased due mainly to expanded sales centered on the Equipment business. Operating income declined in the Chemicals and Processing businesses due to higher raw material prices, utility costs, personnel expenses and depreciation. The foreign exchange translation impact was an approximately ¥643 million decrease in net sales and an approximately ¥80 million decrease in operating income.
Disclosure regarding the going concern assumption
No applicable matters ("There are no applicable matters")
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent eventsEffective 1 April 2026, the Processing business will be transferred through an absorption-type company split to パーカー加工株式会社, which will change its corporate name to パーカープロセッシング株式会社. In addition, 北海道パーカライジング株式会社 will be absorbed through a merger.
Impairment loss805 Millions of yen
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets 213 Millions of yen, Gain on sale of investment securities 4,235 Millions of yen, Other 342 Millions of yen / Extraordinary loss Loss on disposal and sale of non-current assets 393 Millions of yen, Loss on reduction of fixed assets 207 Millions of yen, Impairment Losses 805 Millions of yen, Business structure improvement expenses 89 Millions of yen, Other 12 Millions of yen
Depreciation and amortization7,218 Millions of yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Institutional investors and analysts / Scheduled date 28 May 2026
Issued Shares at Period-End132,604,524
Treasury Shares at Period-End24,351,467
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | 138,155 Millions of yen (YoY +4.4%) |
| Operating profit | 14,814 Millions of yen (YoY -1.2%) |
| Ordinary income | 19,667 Millions of yen (YoY -1.3%) |
| Profit attributable to owners of the parent | 12,940 Millions of yen (YoY -1.3%) |
| Net income per share | ¥117.16 |
| Operating Margin | 10.7% |
| Equity ratio | End of the current fiscal period 73.9% / End of previous period 73.0% |
| Total assets | 273,094 Millions of yen |
| Net assets | 221,457 Millions of yen |
| Cash flows from operating activities | 25,402 Millions of yen |
| Cash flows from investing activities | 617 Millions of yen |
| Cash flows from financing activities | -25,857 Millions of yen |
| Cash and cash equivalents at end of period | 53,849 Millions of yen |
| Full-year earnings forecast | Net Sales 134,000 Millions of yen (YoY -3.0%) / Operating profit 15,000 Millions of yen (YoY +1.3%) / Ordinary income 19,000 Millions of yen (YoY -3.4%) / Profit attributable to owners of the parent 14,000 Millions of yen (YoY +8.2%) |
| Annual Dividend Forecast | ¥50 per share → ¥50 per share（0.0%） |
| Payout ratio | Actual results for the fiscal year ending March 2026 42.7 % / Forecast for the fiscal year ending March 2027 35.8 % |
| Shareholder Return Policy | A consolidated dividend payout ratio of 30% is the target. The Company intends to maintain stable dividends and take the total payout ratio into consideration while flexibly conducting share repurchases. |
| Segment revenue | Pharmaceuticals business 58,919 Millions of yen (YoY +2.3%), Equipment business 27,621 Millions of yen (YoY +14.1%), Processing Business 48,570 Millions of yen (YoY +1.7%), Other (outside reportable segments) 3,043 Millions of yen (YoY +12.6%) |
| Segment profit | Pharmaceuticals business 9,363 Millions of yen (YoY -9.4%), Equipment business 2,116 Millions of yen (YoY +208.5%), Processing Business 4,675 Millions of yen (YoY -6.8%), Other (outside reportable segments) -19 Millions of yen (YoY -125.4%) |
| Regional sales | 82,940 Millions of yen (YoY +3.6%), 48,892 Millions of yen (YoY +7.2%), 11,689 Millions of yen (YoY -3.8%) |
| Depreciation and amortization | 7,218 Millions of yen |
| Impairment loss | 805 Millions of yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets 213 Millions of yen, Gain on sale of investment securities 4,235 Millions of yen, Other 342 Millions of yen / Extraordinary loss Loss on disposal and sale of non-current assets 393 Millions of yen, Loss on reduction of fixed assets 207 Millions of yen, Impairment Losses 805 Millions of yen, Business structure improvement expenses 89 Millions of yen, Other 12 Millions of yen |
| Disclosure regarding the going concern assumption | No applicable matters ("There are no applicable matters") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | Effective 1 April 2026, the Processing business will be transferred through an absorption-type company split to パーカー加工株式会社, which will change its corporate name to パーカープロセッシング株式会社. In addition, 北海道パーカライジング株式会社 will be absorbed through a merger. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts / Scheduled date 28 May 2026 |
| Issued Shares at Period-End | 132,604,524 |
| Treasury Shares at Period-End | 24,351,467 |
| Factors Behind Changes in Business Performance | Net sales increased due mainly to expanded sales centered on the Equipment business. Operating income declined in the Chemicals and Processing businesses due to higher raw material prices, utility costs, personnel expenses and depreciation. The foreign exchange translation impact was an approximately ¥643 million decrease in net sales and an approximately ¥80 million decrease in operating income. |
Items this document does not state (2)
Revision to Earnings ForecastOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased due mainly to expanded sales in the Equipment business, while higher raw material prices, utility costs, personnel expenses and depreciation in the Chemicals and Processing businesses weighed on profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.